These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9567218)

  • 1. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C; Liu XH; Abbate M; Corna D; Schiffrin EL; Remuzzi G; Benigni A
    Exp Nephrol; 1998; 6(2):121-31. PubMed ID: 9567218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
    Benigni A; Tomasoni S; Gagliardini E; Zoja C; Grunkemeyer JA; Kalluri R; Remuzzi G
    J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
    Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
    Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
    Benigni A; Corna D; Maffi R; Benedetti G; Zoja C; Remuzzi G
    Kidney Int; 1998 Aug; 54(2):353-9. PubMed ID: 9690201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
    Zoja C; Corna D; Camozzi D; Cattaneo D; Rottoli D; Batani C; Zanchi C; Abbate M; Remuzzi G
    J Am Soc Nephrol; 2002 Dec; 13(12):2898-908. PubMed ID: 12444208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
    Benigni A; Colosio V; Brena C; Bruzzi I; Bertani T; Remuzzi G
    Diabetes; 1998 Mar; 47(3):450-6. PubMed ID: 9519753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease.
    Abbate M; Zoja C; Rottoli D; Corna D; Perico N; Bertani T; Remuzzi G
    J Am Soc Nephrol; 1999 Apr; 10(4):804-13. PubMed ID: 10203365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin antagonists and renal protection.
    Benigni A; Perico N; Remuzzi G
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
    Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
    Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How renal cytokines and growth factors contribute to renal disease progression.
    Benigni A; Remuzzi G
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S21-4. PubMed ID: 11158856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
    Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
    Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.